Order Article Reprints

Qureshi KA, Imtiaz M, Al Nasr I, Koko WS, Khan TA, Jaremko M, Mahmood S, Fatmi MQ. Antiprotozoal Activity of Thymoquinone (2-Isopropyl-5-methyl-1,4-benzoquinone) for the Treatment of Leishmania major-Induced Leishmaniasis: In Silico and In Vitro Studies. Antibiotics. 2022; 11(9):1206. https://doi.org/10.3390/antibiotics11091206

Qureshi, Kamal A., Mahrukh Imtiaz, Ibrahim Al Nasr, Waleed S. Koko, Tariq A. Khan, Mariusz Jaremko, Syed Mahmood, and M. Qaiser Fatmi. 2022. "Antiprotozoal Activity of Thymoquinone (2-Isopropyl-5-methyl-1,4-benzoquinone) for the Treatment of Leishmania major-Induced Leishmaniasis: In Silico and In Vitro Studies" Antibiotics 11, no. 9: 1206. https://doi.org/10.3390/antibiotics11091206

Qureshi, K. A., Imtiaz, M., Al Nasr, I., Koko, W. S., Khan, T. A., Jaremko, M., Mahmood, S., & Fatmi, M. Q. (2022). Antiprotozoal Activity of Thymoquinone (2-Isopropyl-5-methyl-1,4-benzoquinone) for the Treatment of Leishmania major-Induced Leishmaniasis: In Silico and In Vitro Studies. Antibiotics, 11(9), 1206. https://doi.org/10.3390/antibiotics11091206